Evidence map›Paper›PMID 35140755›Full record

ArticleJournal of otology2022

FDA MAUDE database analysis of titanium middle ear prosthesis.

Jaclyn Carey, Sairisheel Gabbireddy, Luke Mammen, Gianna Rosamilia, Varun Patel, David Foyt, Steven Parnes

Abstract read
In one paragraph

Article in Journal of otology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Titanium Biohybrid Middle Ear Prostheses: A PreliminaryJournal of functional biomaterials · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jaclyn CareyDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Sairisheel GabbireddyDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Luke MammenDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Gianna RosamiliaDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Varun PatelDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
David FoytDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.
Steven ParnesDepartment of Otolaryngology- Head and Neck Surgery, Albany Medical Center, 43 New Scotland Avenue, Albany, NY, 12208, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposePartial ossicular replacement (PORP) and total ossicular replacement prostheses (TORP) are used to restore ossicular chain function. Despite favorable auditory outcomes, these interventions have associated risks and complications. This study examines the FDA MAUDE database for ossicular chain prosthesis adverse events to highlight complications, interventions, and root cause analysis (RCA) findings. MATERIALS AND

methodsThe MAUDE database was searched for Medical Device Reports (MDRs) relating to PORPs and TORPs from 2010 to 2020. MDR event descriptions were reviewed, and adverse events were identified as a device issue, patient issue, and/or packaging issue that occurred intraoperatively or postoperatively.

resultsOur search identified 70 MDRs which included 110 reported adverse events. Events consisted of 63 device issues, often due to device breaks and displacements, 39 patient issues, including common complaints of hearing loss and erosion, and 8 packaging issues. When comparing PORPs and TORPs, TORPs had more reported device issues whereas PORPs had more packaging issues. Intraoperative device issues were commonly resolved by completing the procedure with a backup device and most postoperative device issues required additional surgery. For devices returned to the manufacturer, RCA determined that most breaks were caused by modification and/or mishandling or that the product met specifications with an undetermined cause for the break.

conclusionDevice issues were the most common adverse events and frequently required subsequent intervention. Displacement occurred more often with TORPs and was associated with changes in hearing or erosion. The findings of this study are purely descriptive and may not have direct clinical relevance.

Indexed as

FDA, U.S. Food and Drug AdministrationMAUDEMAUDE, Manufacturer and User Facility Device ExperienceMDR, Medical device reportMedical devicesOCR, Ossicular chain replacementOssicular chain reconstructionPORPPORP, Partial ossicular replacement prosthesisRCA, Root cause analysisTORPTORP, Total ossicular replacement prosthesis

Identifiers

PMID35140755
PMCPMC8811412

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.